Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

NantKwest Inc (NK) USD0.0001

Sell:$1.32 Buy:$1.34 Change: $0.07 (5.51%)
NASDAQ:0.90%
Market closed |  Prices as at close on 21 August 2019 | Switch to live prices |
Sell:$1.32
Buy:$1.34
Change: $0.07 (5.51%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed |  Prices as at close on 21 August 2019 | Switch to live prices |
Sell:$1.32
Buy:$1.34
Change: $0.07 (5.51%)
Market closed |  Prices as at close on 21 August 2019 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Its immuno-oncology NK platform has multiple modes to induce cell death against the tumor or infected cell by direct killing by binding to stress ligands expressed by the diseased cell with the release of toxic granules directly into the tumor cell; antibody mediated killing by binding to antibodies administered in combination and enhancing the cancer killing effect of the administered antibody, enabling targeted cell killing through antibody dependent cellular cytotoxicity (ADCC), and target activated killing by binding to known or newly discovered tumor-specific antigens expressed on the surface of tumor cells and inducing cell death by the release of toxic granules directly into the tumor cell and by the release of cytokines and chemokines.

Contact details

Address:
3530 John Hopkins Ct
SAN DIEGO
92121-1121
United States
Telephone:
+1 (858) 6330300
Website:
https://www.nantkwest.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NK
ISIN:
US63016Q1022
Market cap:
$124.85 million
Shares in issue:
98.31 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Patrick Soon-Shiong
    Chairman of the Board, Chief Executive Officer
  • Barry Simon
    President, Chief Administrative Officer, Director
  • Steven Gorlin
    Vice Chairman of the Board
  • Sonja Nelson
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.